ZELBORAF Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zelboraf, and when can generic versions of Zelboraf launch?
Zelboraf is a drug marketed by Hoffmann La Roche and is included in one NDA. There are six patents protecting this drug.
This drug has one hundred and ninety-eight patent family members in forty-six countries.
The generic ingredient in ZELBORAF is vemurafenib. One supplier is listed for this compound. Additional details are available on the vemurafenib profile page.
DrugPatentWatch® Generic Entry Outlook for Zelboraf
Zelboraf was eligible for patent challenges on August 17, 2015.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be June 6, 2032. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZELBORAF?
- What are the global sales for ZELBORAF?
- What is Average Wholesale Price for ZELBORAF?
Summary for ZELBORAF
| International Patents: | 198 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 139 |
| Clinical Trials: | 53 |
| Patent Applications: | 3,419 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ZELBORAF |
| What excipients (inactive ingredients) are in ZELBORAF? | ZELBORAF excipients list |
| DailyMed Link: | ZELBORAF at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ZELBORAF
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ZELBORAF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cancer Research UK | Phase 2/Phase 3 |
| Royal Marsden NHS Foundation Trust | Phase 2/Phase 3 |
| University of Manchester | Phase 2/Phase 3 |
Pharmacology for ZELBORAF
| Drug Class | Kinase Inhibitor |
| Mechanism of Action | Cytochrome P450 1A2 Inhibitors P-Glycoprotein Inhibitors Protein Kinase Inhibitors |
US Patents and Regulatory Information for ZELBORAF
ZELBORAF is protected by seven US patents and one FDA Regulatory Exclusivity.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of ZELBORAF is ⤷ Sign Up.
This potential generic entry date is based on patent ⤷ Sign Up.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting ZELBORAF
Compounds and methods for development of Ret modulators
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compounds and methods for kinase modulation, and indications therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compounds and methods for kinase modulation, and indications therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compounds and methods for kinase modulation, and indications therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ZELBORAF IS INDICATED FOR THE TREATMENT OF PATIENTS WITH ERDHEIM-CHESTER DISEASE WITH BRAF V600 MUTATION
Compounds and methods for kinase modulation, and indications therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATMENT OF PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH BRAFV600E MUTATION AS DETECTED BY AN FDA APPROVED TEST
Process for the manufacture of pharmaceutically active compounds
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Compositions and uses thereof
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
FDA Regulatory Exclusivity protecting ZELBORAF
TREATMENT OF PATIENTS WITH ERDHEIM-CHESTER DISEASE WITH BRAF V600 MUTATION
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for ZELBORAF
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Roche Registration GmbH | Zelboraf | vemurafenib | EMEA/H/C/002409 Vemurafenib is indicated in monotherapy for the treatment of adult patients with BRAF-V600-mutation-positive unresectable or metastatic melanoma., |
Authorised | no | no | no | 2012-02-17 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for ZELBORAF
When does loss-of-exclusivity occur for ZELBORAF?
Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:
Argentina
Patent: 8033
Patent: UNA DISPERSION SOLIDA, QUE CONTIENE AL COMPUESTO {3-[5-(4-(CLORO-FENIL)-1H-PIRROLO[2,3-B]PIRIDINA-3-CARBONIL]-2,4-DIFLUOR-FENIL}-AMIDA DEL ACIDO PROPANO-1-SULFONICO, COMPOSICIONES Y FORMULACIONES QUE COMPRENDEN A DICHA DISPERSION SOLIDA; METODOS PARA FABRICAR DICHA DISPERSION SOLIDA, FORMAS 1 Y 2 DE
Estimated Expiration: ⤷ Sign Up
Patent: 1037
Patent: COMPOSICIONES Y USOS DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Australia
Patent: 10232670
Patent: Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Patent: 10318049
Patent: Propane-I-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-B]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Patent: 15238857
Patent: Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Brazil
Patent: 1008709
Patent: composições e usos das mesmas.
Estimated Expiration: ⤷ Sign Up
Patent: 2012009609
Patent: método para fabricar uma dispersão sólida, dispersão sólida , preparação farmacêutica e composições
Estimated Expiration: ⤷ Sign Up
Patent: 2020005420
Patent: forma purificada 1 do polimorfo cristalino do composto i
Estimated Expiration: ⤷ Sign Up
Canada
Patent: 38573
Patent: COMPOSITIONS ET UTILISATIONS ASSOCIEES (COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Patent: 78693
Patent: COMPOSITIONS DE {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO(2,3-B)PYRIDINE-3-CARBONYL]-2,4-DIFLUOROPHENYL)}-AMIDE DE L'ACIDE PROPANE-1-SULFONIQUE ET LEURS UTILISATIONS (PROPANE-I-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
China
Patent: 1761378
Patent: X-tube and accompanying exhaust gas assembly
Estimated Expiration: ⤷ Sign Up
Patent: 2361870
Patent: Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Patent: 2596953
Patent: Propane-i-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Patent: 5237530
Patent: Propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Patent: 0269838
Patent: 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途 (Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof)
Estimated Expiration: ⤷ Sign Up
Colombia
Patent: 10296
Patent: COMPOSICIONES DEL ÁCIDO PROPANO-1-SULFÓNICO {3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Costa Rica
Patent: 110420
Patent: COMPOSICIONES DEL ACIDO PROPANO-1-SULFONICO {3-[5-(4-CLORO-FENIL) -1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Patent: 170089
Patent: COMPOSICIONES DEL ACIDO PROPANO-1--SULFONICO {3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Croatia
Patent: 0151156
Estimated Expiration: ⤷ Sign Up
Cyprus
Patent: 16983
Estimated Expiration: ⤷ Sign Up
Denmark
Patent: 14356
Estimated Expiration: ⤷ Sign Up
Dominican Republic
Patent: 011000291
Patent: COMPOSICIONES DEL ACIDO PROPANO-1-SULFONICO{3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Ecuador
Patent: 11011282
Patent: COMPOSICIONES DEL ÁCIDO PROPANO-1-SULFÓNICO {3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-b]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
El Salvador
Patent: 11004004
Patent: COMPOSICIONES DEL ACIDO PROPANO-1-SULFONICO {3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Eurasian Patent Organization
Patent: 2924
Patent: ТВЁРДАЯ ФОРМА {3-[5-(4-ХЛОРФЕНИЛ)-1Н-ПИРРОЛО[2,3-b]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ И ЕЁ ПРИМЕНЕНИЕ (SOLID FORM OF PROPANE-1-SULFONIC ACID {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUOROPHENYL}AMIDE AND USE THEREOF)
Estimated Expiration: ⤷ Sign Up
Patent: 1116
Patent: КРИСТАЛЛИЧЕСКИЕ ПОЛИМОРФНЫЕ ФОРМЫ {3-[5-(4-ХЛОРФЕНИЛ)-1H-ПИРРОЛО[2,3-b]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ (PROPANE-1-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-b]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}AMIDE CRYSTALLINE POLYMORPH FORMS)
Estimated Expiration: ⤷ Sign Up
Patent: 1190098
Patent: КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
Estimated Expiration: ⤷ Sign Up
Patent: 1591240
Patent: КОМПОЗИЦИИ {3-[5-(4-ХЛОРФЕНИЛ)-1H-ПИРРОЛО[2,3-B]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ И ИХ ПРИМЕНЕНИЕ
Estimated Expiration: ⤷ Sign Up
European Patent Office
Patent: 99559
Patent: Tuyau X et installation de gaz d'échappement correspondante (X-tube and accompanying exhaust gas assembly)
Estimated Expiration: ⤷ Sign Up
Patent: 14356
Patent: COMPOSITIONS DE {3-[5-(4-CHLOROPHÉNYL)-1H-PYRROLO(2,3-B)PYRIDINE-3-CARBONYL]-2,4-DIFLUOROPHÉNYL)}-AMIDE DE L'ACIDE PROPANE-1-SULFONIQUE ET LEURS UTILISATIONS (PROPANE-I-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Patent: 99138
Patent: COMPOSITIONS DE {3-[5-(4-CHLOROPHÉNYL)-1H-PYRROLO(2,3-B)PYRIDINE-3-CARBONYL]-2,4-DIFLUOROPHÉNYL)}-AMIDE DE L'ACIDE PROPANE-1-SULFONIQUE ET LEURS UTILISATIONS (PROPANE-I-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Patent: 55180
Patent: COMPOSITIONS D'ACIDE PROPANE-I-SULFONIQUE {3- [5- (4- CHLORO-PHÉNYLE) -1H-PYRROLO [2,3-B} PYRIDINE-3-CARBONYLE] -2,4-DIFLUORO-PHÉNYLE} -AMIDE ET LEURS UTILISATIONS (PROPANE-I-SULFONIC ACID {3- [5- (4- CHLORO-PHENYL) -1H-PYRROLO [2, 3-B} PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENYL} -AMIDE COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Germany
Patent: 2008061829
Patent: X-Rohr und zugehörige Abgasanlage
Estimated Expiration: ⤷ Sign Up
Honduras
Patent: 11002147
Patent: COMPOSICIONES DEL ACIDO PROPANO -1-SULFONICO{3-[5-(4-CLORO-FENIL)-11H-PIRROLO[2,3-B]-PIRIDINA-3-CARBONIL]-2,4 DIFLUORO-FENIL]-AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Hong Kong
Patent: 68590
Patent: } - 丙烷- -磺酸{ -氯-苯基 -吡咯並 吡啶- -羰基 -二氟-苯基}-醯胺組合物及其用途 (PROPANE- I-SULFONIC ACID 3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENYL -AMIDE COMPOSITIONS AND USES THEREOF -1-3-[5-(4--)-1H-[23-B]-3-]-24---)
Estimated Expiration: ⤷ Sign Up
Patent: 17195
Patent: } - 丙烷- -磺酸{ -氯-苯基 -吡咯並 吡啶- -羰基 -二氟-苯基}-醯胺組合物及其用途 (PROPANE I SULFONIC ACID 3 [5 (4 CHLORO PHENYL) 1H PYRROLO [2, 3 B PYRIDINE 3 CARBONYL] 2, 4 DIFLUORO PHENYL AMIDE COMPOSITIONS AND USES THEREOF 1 3 [5 (4 ) 1H [23 B] 3 ] 24)
Estimated Expiration: ⤷ Sign Up
Hungary
Patent: 27598
Estimated Expiration: ⤷ Sign Up
Israel
Patent: 4328
Patent: דיספרסיה מוצקה של פרופאן-1-חומצה סולפונית {3-[5-(4-כלורו-פניל)-1h-פירולו[3,2-b] פירידין-3-קרבוניל]-4,2-דיפלואורו-פניל}-אמיד תכשיר המכיל אותה ושיטה להכנתה (Solid dispersion comprising propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo [2,3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, composition comprising the same and method for making the solid dispersion)
Estimated Expiration: ⤷ Sign Up
Patent: 1336
Patent: תכשירי פרופאן-1-חומצה סולפונית {3-[5-(4-כלורו-פניל)-h1-פירולו[b-3,2] פירידין-3-קרבוניל]-4,2-דיפלואורו-פניל}-אמיד ושימושים בהם (Propane-1-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-phenyl } -amide compositions and uses thereof)
Estimated Expiration: ⤷ Sign Up
Japan
Patent: 11942
Estimated Expiration: ⤷ Sign Up
Patent: 12522791
Estimated Expiration: ⤷ Sign Up
Patent: 13510813
Estimated Expiration: ⤷ Sign Up
Jordan
Patent: 56
Patent: تركيبات { 3-[5-(4-كلورو-فينيل )-أ1-بيرلو [2, 3-ب] بيريدين-3-كربونيل ] -2, 4- ثاني فلورو-فينيل } -أميد بروبان-1-حمض سلفونيك واستخداماتها (PROPANE-1-SULFONIC ACID { 3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO [2,3-B] PYRIDINE -3-CARBONYL]-2,4-DIFLUORO-PHENYL} AMIDE COMPOSITION AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Malaysia
Patent: 0737
Patent: PROPANE-I-SULFONIC ACID {3- [5-(4-CHLORO-PHENYL) -1H -PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2,4 DIFLUORO-PHENYL} - AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Patent: 2424
Patent: PROPANE- I-SULFONIC ACID {3- (4-CHLORO-PHENYL)-1H-PYRROLO [2, 3-B] PYRIDINE-3-CARCONYL] -2, 4-DIFLUORO-PHENYL} -AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Mexico
Patent: 9923
Patent: COMPOSICIONES DEL ÁCIDO PROPANO-1-SULFÓNICO {3-[5-(4-CLORO-FENIL)- 1H-PIRROLO [2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL]-AMIDA Y EL USO DE LAS MISMAS. (PROPANE- I-SULFONIC ACID {3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENY L } -AMIDE COMPOSITIONS AND USES THEREOF.)
Estimated Expiration: ⤷ Sign Up
Patent: 11008303
Patent: COMPOSICIONES DEL ACIDO PROPANO-1-SULFONICO {3-[5-(4-CLORO-FENIL)- 1H-PIRROLO [2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS. (PROPANE- I-SULFONIC ACID {3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENY L } -AMIDE COMPOSITIONS AND USES THEREOF.)
Estimated Expiration: ⤷ Sign Up
Patent: 12005224
Patent: NUEVO PROCESO PARA LA MANUFACTURA DE PREPARACIONES FARMACEUTICAS. (PROPANE-I-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B] PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF.)
Estimated Expiration: ⤷ Sign Up
Morocco
Patent: 028
Patent: تراكيب واستخدامات مرتبطة بها
Estimated Expiration: ⤷ Sign Up
New Zealand
Patent: 4398
Patent: Propane-1-sulfonic acid (3-[5-(4-chloro-phenyl)-1h-pyrrol [2, 3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl} -amide compositions and uses thereof
Estimated Expiration: ⤷ Sign Up
Nicaragua
Patent: 1100161
Patent: COMPOSICIONES DEL ÁCIDO PROPANO - 1 - SULFÓNICO { 3 - [5 - (4 - CLORO - FENIL) - 1H - PIRROLO [2, 3-b] - PIRIDINA - 3 - CARBONIL] - 2, 4 - DIFLUORO - FENIL} - AMIDA Y EL USO DE LAS MISMAS
Estimated Expiration: ⤷ Sign Up
Peru
Patent: 120876
Patent: COMPOSICIONES DEL ACIDO PROPANO-1-SULFONICO{3-[5-(4-CLORO-FENIL)-1H-PIRROLO[2,3-B]-PIRIDINA-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMIDA
Estimated Expiration: ⤷ Sign Up
Poland
Patent: 14356
Estimated Expiration: ⤷ Sign Up
Portugal
Patent: 14356
Estimated Expiration: ⤷ Sign Up
Russian Federation
Patent: 12123958
Patent: КОМПОЗИЦИИ {3-[5-(4-ХЛОРФЕНИЛ)-1Н-ПИРРОЛО[2, 3]ПИРИДИН-3-КАРБОНИЛ]-2,4-ДИФТОРФЕНИЛ}АМИДА ПРОПАН-1-СУЛЬФОНОВОЙ КИСЛОТЫ И ИХ ПРИМЕНЕНИЕ
Estimated Expiration: ⤷ Sign Up
San Marino
Patent: 01500302
Patent: COMPOSIZIONI DI {3-[5-(4-CLORO-FENIL)-1H-PIRROLO[2,3-B]PIRIDIN-3-CARBONIL]-2,4-DIFLUORO-FENIL}-AMMIDE DELL'ACIDO PROPAN-1-SOLFONICO E LORO USI
Estimated Expiration: ⤷ Sign Up
Singapore
Patent: 3178
Patent: PROPANE- I-SULFONIC ACID {3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENY L } -AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Slovenia
Patent: 14356
Estimated Expiration: ⤷ Sign Up
South Africa
Patent: 1202937
Patent: PROPANE-I-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
South Korea
Patent: 1739994
Estimated Expiration: ⤷ Sign Up
Patent: 120006006
Patent: PROPANE-1-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Patent: 120101439
Patent: PROPANE-1-SULFONIC ACID {3-[5-(4-CHLORO-PHENYL)-1H-PYRROLO[2,3-B]PYRIDINE-3-CARBONYL]-2,4-DIFLUORO-PHENYL}-AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Patent: 170058465
Patent: 프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도 (-- ------------- PROPANE-1-SULFONIC ACID 3-5-4-CHLORO-PHENYL-1H-PYRROLO23-BPYRIDINE-3-CARBONYL-24-DIFLUORO-PHENYL-AMIDE COMPOSITIONS AND USES THEREOF)
Estimated Expiration: ⤷ Sign Up
Spain
Patent: 52386
Estimated Expiration: ⤷ Sign Up
Taiwan
Patent: 04719
Estimated Expiration: ⤷ Sign Up
Patent: 1040179
Patent: Compositions and uses therof
Estimated Expiration: ⤷ Sign Up
Tunisia
Patent: 11000436
Patent: PROPANE- I-SULFONIC ACID {3- [5- (4 -CHLORO-PHENYL) -1H-PYRROLO [2, 3-B] PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENY L } -AMIDE COMPOSITIONS AND USES THEREOF
Estimated Expiration: ⤷ Sign Up
Ukraine
Patent: 8842
Patent: ТВЕРДА ДИСПЕРСІЯ, СПОСІБ ЇЇ ОДЕРЖАННЯ, А ТАКОЖ КОМПОЗИЦІЯ І ЛІКАРСЬКА ФОРМА, ЩО ЇЇ МІСТЯТЬ
Estimated Expiration: ⤷ Sign Up
Uruguay
Patent: 540
Patent: COMPOSICIONES QUE INCLUYEN COMPUESTOS QUE CONTIENEN LA {3-[5-(4-CLORO-FENIL)-1H-PIRROLO[2,3-B]PIRIDINA-3-CARBONIL]-2,4-DIFLUOR-FENIL}-AMIDA DEL ÁCIDO PROPANO-1-SULFÓNICO Y MÉTODOS PARA FABRICAR ESTAS COMPOSICIONES
Estimated Expiration: ⤷ Sign Up
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
See the table below for additional patents covering ZELBORAF around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Costa Rica | 20170089 | COMPOSICIONES DEL ACIDO PROPANO-1--SULFONICO {3-[5-(4-CLORO-FENIL)-1H-PIRROLO [2,3-B] PIRIDINA-3-CARBONIL] -2,4-DIFLUORO-FENIL}-AMIDA Y EL USO DE LAS MISMAS | ⤷ Sign Up |
| Taiwan | I404719 | ⤷ Sign Up | |
| South Korea | 101461291 | ⤷ Sign Up | |
| Portugal | 2414356 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZELBORAF
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1893612 | 122012000043 | Germany | ⤷ Sign Up | PRODUCT NAME: VEMURAFENIB ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ DAVON; REGISTRATION NO/DATE: EU/1/12/751/001 20120217 |
| 1893612 | 122 5012-2012 | Slovakia | ⤷ Sign Up | FIRST REGISTRATION NO/DATE: EU/1/12/751/001, 20120217 |
| 1893612 | CA 2012 00028 | Denmark | ⤷ Sign Up | |
| 1893612 | C01893612/01 | Switzerland | ⤷ Sign Up | VERTRETERLOESCHUNG |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
